| Source: |
Semisynthetic. Made from aflatoxin B1from Aspergillus flavus |
| Synonyms |
|
| Description: |
8,9-dihidro derivate of aflatoxin B1. Apotent hepatotoxic and hepatocarcinogenic mycotoxin |
| CAS number: |
7220-81-7 |
| Merck index: |
12,178 |
| Molecular weight: |
314.3 |
| Structure: |
 |
| Molecular Formula: |
C17H14O6 |
Solubility
information: |
DMSO or MeOH |
| Specifications |
|
| Appearance: |
Off - white powder; blue fluorescence |
| Purity: |
At least 98% by TLC |
λmax: |
|
| Melting point |
|
| Solubility |
|
| Storage |
-20°C |
| Applications |
|
| Warnings |
 TOXIC
CARCINOGEN |
| Classification |
Furano-furano-Benzopyranmycotoxin
Aflatoxin |
| Related products |
Aflatoxin B1 , B2, G1, G2, M1, M2 |
| |
For Research use only. Not for Human or Drug use
GMP/API grade available on request
No genetically modified organisms are used. |
| Publications |
|
| |
Groopman JD, Fowler KW, Busby WF Jr, Wogan GN.
Interaction of aflatoxin B2 with rat liver DNA and histones in vivo.
Carcinogenesis. 1981;2(12):1371-3. |
| |
Roebuck BD, Siegel WG, Wogan GN.
In vitro metabolism of aflatoxin B2 by animal and human liver.
Cancer Res. 1978 Apr;38(4):999-1002. |
|
|
